Evidence map›Paper›PMID 40298560›Full record

ArticleAntibiotics (Basel, Switzerland)2025

Design and Validation of a Simplified Method to Determine Minimum Bactericidal Concentration in Nontuberculous Mycobacteria.

Sara Batista, Mariana Fernández-Pittol, Lorena San Nicolás, Diego Martínez, Sofía Narváez, Mateu Espasa, Elena Garcia Losilla, Marc Rubio, Montserrat Garrigo, Griselda Tudó and 1 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sara BatistaUnitat de Microbiologia, Departament de Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, c/Casanova 143, 08036 Barcelona, Spain.
Mariana Fernández-PittolUnitat de Microbiologia, Departament de Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, c/Casanova 143, 08036 Barcelona, Spain.
Lorena San NicolásServei de Microbiologia, CDB, Hospital Clínic de Barcelona, c/Villarroel 170, 08036 Barcelona, Spain.
Diego MartínezServei de Microbiologia, CDB, Hospital Clínic de Barcelona, c/Villarroel 170, 08036 Barcelona, Spain.
Sofía NarváezCatlab, Centre Analítiques Terrassa AIE, Servei de Microbiologia Vallès Occidental, Parc Logístic de Salut, Viladecavalls, 08232 Terrassa, Spain.
Mateu EspasaUnitat de Microbiologia, Departament de Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, c/Casanova 143, 08036 Barcelona, Spain.ORCID 0000-0003-4822-1024
Elena Garcia LosillaServei de Microbiologia, Fundació de Gestió de l'Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
Marc RubioServei de Microbiologia, Fundació de Gestió de l'Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.ORCID 0000-0002-4811-0642
Montserrat GarrigoServei de Microbiologia, Fundació de Gestió de l'Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
Griselda TudóUnitat de Microbiologia, Departament de Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, c/Casanova 143, 08036 Barcelona, Spain.ORCID 0000-0002-9241-7051
Julian González-MartinUnitat de Microbiologia, Departament de Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, c/Casanova 143, 08036 Barcelona, Spain.ORCID 0000-0001-7248-6706

Funding

CIIBER-Consorcio Centro de Investigación Biomédica en Red Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea-NextGenerationEU CB21/13/00081Generalitat de Catalunya through the "CERCA" Program CEX2023-0001290-SMinisterio de Economía y Competitividad, Instituto de Salud Carlos III , cofinanced by European Regional Development Fund (ERDF, FEDER) "A Way to Achieve Eu-rope," the Spanish Ministry of Health PI2200536SB receives a grant from INTENSE-TBM research consortium, Fundació de Recerca Clínic Barcelona -Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain RIA2017T-2019the Sociedad Española de Neumología y Cirugía Torácica (SEPAR), by grant from Departament d'Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya 2021SGR01569
6 · The paper itself

Abstract

BACKGROUND/

objectivesNontuberculous mycobacteria (NTM) infections are rising, particularly those by

methodsFirst, we assessed the stability of the antibiotics included in SLOWMYCOI Sensititre™ microtiter plates. Five strains of MAC were studied comparing the minimum inhibitory concentrations (MICs) of those preincubated for seven days vs. non-incubated plates. Then, we evaluated the percentage of reproducibility of MBC values using two methods, reincubation and subculturing (standard or traditional method) in 30 MAC isolates. Finally, we validated the reincubation method and prospectively determined the MBC values of the 229 NTM clinical strains.

resultsAntibiotic stability: The MIC was equivalent after 7 and 14 days for all the antibiotics, except rifampicin, for which the MIC increased by 2- to 3-fold after preincubation. Reincubation method: The percentage of reproducibility of the MBC values between the two methods was 95.2% (range 76.6% to 100%). Prospective validation: MBC/MIC ratios revealed differential bactericidal activity for most antibiotics according to the different species, being bactericidal in

conclusionsPreincubation of Sensititre™ microtiter plates did not alter the MIC values of the antibiotics included except for rifampicin, suggesting a loss of activity. MBC determination can be easily performed by the Reincubation method presented. MBC values provide useful additional information regarding MIC values since the MBC/MIC ratio reveals whether antibiotics have bactericidal or bacteriostatic activity according to the species, which is pivotal for selecting the most adequate antibiotic combination to ensure efficient treatment management.

Indexed as

antibioticsbacteriostatic/bactericidal activityminimum bactericidal concentration (MBC)nontuberculous mycobacteria (NTM)reincubation methodSLOMYCOI Sensititresubculturing method

Identifiers

PMID40298560
PMCPMC12023921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.